loader
Please Wait
Applying Filters...

Seqens Seqens

X

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Rotigotine to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 BASF (11)

filter

01 Capsule (3)

02 Tablet (3)

03 Topical Film (1)

04 Transdermal Patch (3)

05 Transdermal patches (1)

filter

01 Germany (11)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form: Capsule, Tablet, Transdermal Patch

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY